Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tri-Point's surgical adhesive cleared in Canada

This article was originally published in Clinica

Executive Summary

Tri-Point Medical LP (US) has received clearance from the Canadian Ministry of Health and Welfare to market its wound- closure adhesive, Traumaseal. The biocompatible adhesive can be used to close wounds from skin lacerations, minimally invasive surgery and plastic surgery. No anaesthesia is required to apply the liquid suture and procedure time is "minimal", says Tri-Point. US FDA export approval has been granted for the product which will be distributed in Canada by Pilling Weck (US).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093353

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel